3.26.1 html 167 222 1 true 63 0 false 4 false false R1.htm 75000 - Document - Document and Entity Information Sheet http://cytokinetics.com/20260331/taxonomy/role/Role_DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 75010 - Statement - Condensed Consolidated Balance Sheets (Unaudited) Sheet http://cytokinetics.com/20260331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited Condensed Consolidated Balance Sheets (Unaudited) Statements 2 false false R3.htm 75030 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) Sheet http://cytokinetics.com/20260331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) Statements 3 false false R4.htm 75040 - Statement - Condensed Consolidated Statements of Stockholders' (Deficit) Equity (Unaudited) Sheet http://cytokinetics.com/20260331/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficitEquityUnaudited Condensed Consolidated Statements of Stockholders' (Deficit) Equity (Unaudited) Statements 4 false false R5.htm 75050 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://cytokinetics.com/20260331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 5 false false R6.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 6 false false R7.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 7 false false R8.htm 995455 - Disclosure - Organization and Significant Accounting Policies Sheet http://cytokinetics.com/20260331/taxonomy/role/Role_DisclosureOrganizationAndSignificantAccountingPolicies Organization and Significant Accounting Policies Notes 8 false false R9.htm 995465 - Disclosure - Net Loss Per Share Sheet http://cytokinetics.com/20260331/taxonomy/role/Role_DisclosureNetLossPerShare Net Loss Per Share Notes 9 false false R10.htm 995475 - Disclosure - Agreements with Royalty Pharma Sheet http://cytokinetics.com/20260331/taxonomy/role/DisclosureAgreementsWithRoyaltyPharma1 Agreements with Royalty Pharma Notes 10 false false R11.htm 995485 - Disclosure - Research and Development Arrangements Sheet http://cytokinetics.com/20260331/taxonomy/role/Role_DisclosureResearchAndDevelopmentArrangements Research and Development Arrangements Notes 11 false false R12.htm 995495 - Disclosure - Fair Value Measurements Sheet http://cytokinetics.com/20260331/taxonomy/role/Role_DisclosureFairValueMeasurements Fair Value Measurements Notes 12 false false R13.htm 995505 - Disclosure - Balance Sheet Components Sheet http://cytokinetics.com/20260331/taxonomy/role/Role_DisclosureBalanceSheetComponents Balance Sheet Components Notes 13 false false R14.htm 995515 - Disclosure - Debt Sheet http://cytokinetics.com/20260331/taxonomy/role/Role_DisclosureDebt Debt Notes 14 false false R15.htm 995525 - Disclosure - Stockholders' Equity Sheet http://cytokinetics.com/20260331/taxonomy/role/Role_DisclosureStockholdersEquity Stockholders' Equity Notes 15 false false R16.htm 995535 - Disclosure - Commitments and Contingencies Sheet http://cytokinetics.com/20260331/taxonomy/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 16 false false R17.htm 995545 - Disclosure - Subsequent Events Sheet http://cytokinetics.com/20260331/taxonomy/role/DisclosureSubsequentEvents Subsequent Events Notes 17 false false R18.htm 995555 - Disclosure - Organization and Significant Accounting Policies (Policies) Sheet http://cytokinetics.com/20260331/taxonomy/role/Role_DisclosureOrganizationAndSignificantAccountingPoliciesPolicies Organization and Significant Accounting Policies (Policies) Policies http://cytokinetics.com/20260331/taxonomy/role/Role_DisclosureOrganizationAndSignificantAccountingPolicies 18 false false R19.htm 995565 - Disclosure - Organization and Significant Accounting Policies (Tables) Sheet http://cytokinetics.com/20260331/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesTables Organization and Significant Accounting Policies (Tables) Tables http://cytokinetics.com/20260331/taxonomy/role/Role_DisclosureOrganizationAndSignificantAccountingPolicies 19 false false R20.htm 995575 - Disclosure - Net Loss Per Share (Tables) Sheet http://cytokinetics.com/20260331/taxonomy/role/Role_DisclosureNetLossPerShareTables Net Loss Per Share (Tables) Tables http://cytokinetics.com/20260331/taxonomy/role/Role_DisclosureNetLossPerShare 20 false false R21.htm 995585 - Disclosure - Agreements with Royalty Pharma (Tables) Sheet http://cytokinetics.com/20260331/taxonomy/role/DisclosureAgreementsWithRoyaltyPharmaTables Agreements with Royalty Pharma (Tables) Tables http://cytokinetics.com/20260331/taxonomy/role/DisclosureAgreementsWithRoyaltyPharma1 21 false false R22.htm 995605 - Disclosure - Fair Value Measurements (Tables) Sheet http://cytokinetics.com/20260331/taxonomy/role/Role_DisclosureFairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://cytokinetics.com/20260331/taxonomy/role/Role_DisclosureFairValueMeasurements 22 false false R23.htm 995615 - Disclosure - Balance Sheet Components (Tables) Sheet http://cytokinetics.com/20260331/taxonomy/role/Role_DisclosureBalanceSheetComponentsTables Balance Sheet Components (Tables) Tables http://cytokinetics.com/20260331/taxonomy/role/Role_DisclosureBalanceSheetComponents 23 false false R24.htm 995625 - Disclosure - Debt (Tables) Sheet http://cytokinetics.com/20260331/taxonomy/role/Role_DisclosureDebtTables Debt (Tables) Tables http://cytokinetics.com/20260331/taxonomy/role/Role_DisclosureDebt 24 false false R25.htm 995635 - Disclosure - Stockholders' Equity (Tables) Sheet http://cytokinetics.com/20260331/taxonomy/role/DisclosureStockholdersEquityTables Stockholders' Equity (Tables) Tables http://cytokinetics.com/20260331/taxonomy/role/Role_DisclosureStockholdersEquity 25 false false R26.htm 995645 - Disclosure - Organization and Significant Accounting Policies - Additional Information (Detail) Sheet http://cytokinetics.com/20260331/taxonomy/role/Role_DisclosureOrganizationAndSignificantAccountingPoliciesAdditionalInformationDetail Organization and Significant Accounting Policies - Additional Information (Detail) Details 26 false false R27.htm 995655 - Disclosure - Organization and Significant Accounting Policies - Schedule of Customers Accounted for Product Revenue (Detail) Sheet http://cytokinetics.com/20260331/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesScheduleOfCustomersAccountedForProductRevenueDetail Organization and Significant Accounting Policies - Schedule of Customers Accounted for Product Revenue (Detail) Details 27 false false R28.htm 995665 - Disclosure - Net Loss Per Share - Instruments Excluded from the Computation of Diluted Net Loss Per Share (Detail) Sheet http://cytokinetics.com/20260331/taxonomy/role/Role_DisclosureNetLossPerShareInstrumentsExcludedFromComputationOfDilutedNetLossPerShareDetail Net Loss Per Share - Instruments Excluded from the Computation of Diluted Net Loss Per Share (Detail) Details 28 false false R29.htm 995675 - Disclosure - Agreements with Royalty Pharma - Additional Information (Detail) Sheet http://cytokinetics.com/20260331/taxonomy/role/DisclosureAgreementsWithRoyaltyPharmaAdditionalInformationDetail Agreements with Royalty Pharma - Additional Information (Detail) Details 29 false false R30.htm 995695 - Disclosure - Agreements with Royalty Pharma - Summary of Changes of Fair Value of Liabilities (Detail) Sheet http://cytokinetics.com/20260331/taxonomy/role/DisclosureAgreementsWithRoyaltyPharmaSummaryOfChangesOfFairValueOfLiabilitiesDetail Agreements with Royalty Pharma - Summary of Changes of Fair Value of Liabilities (Detail) Details 30 false false R31.htm 995705 - Disclosure - Agreements with Royalty Pharma - Schedule Represents Allocation of Transaction Consideration on a Relative Fair Value Basis to the Liability and the Common Stock (Detail) Sheet http://cytokinetics.com/20260331/taxonomy/role/DisclosureAgreementsWithRoyaltyPharmaScheduleRepresentsAllocationOfTransactionConsiderationOnARelativeFairValueBasisToTheLiabilityAndThe Agreements with Royalty Pharma - Schedule Represents Allocation of Transaction Consideration on a Relative Fair Value Basis to the Liability and the Common Stock (Detail) Details 31 false false R32.htm 995735 - Disclosure - Agreements with Royalty Pharma - Summary of Changes of Fair Value of Derivative Liabilities (Detail) Sheet http://cytokinetics.com/20260331/taxonomy/role/DisclosureAgreementsWithRoyaltyPharmaSummaryOfChangesOfFairValueOfDerivativeLiabilitiesDetail Agreements with Royalty Pharma - Summary of Changes of Fair Value of Derivative Liabilities (Detail) Details 32 false false R33.htm 995755 - Disclosure - Research and Development Arrangements - Additional Information (Detail) Sheet http://cytokinetics.com/20260331/taxonomy/role/DisclosureResearchAndDevelopmentArrangementsAdditionalInformationDetail Research and Development Arrangements - Additional Information (Detail) Details 33 false false R34.htm 995765 - Disclosure - Fair Value Measurements - Summary of Fair Value of Financial Assets Consists of Cash Equivalents and Investments Classified as Available-for-sale Securities Measured on Recurring Basis (Detail) Sheet http://cytokinetics.com/20260331/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFairValueOfFinancialAssetsConsistsOfCashEquivalentsAndInvestmentsClassifiedAsAvailableForSaleSecuritiesMeasuredOnRecurringBasisDetail Fair Value Measurements - Summary of Fair Value of Financial Assets Consists of Cash Equivalents and Investments Classified as Available-for-sale Securities Measured on Recurring Basis (Detail) Details 34 false false R35.htm 995775 - Disclosure - Fair Value Measurements - Additional Information (Detail) Sheet http://cytokinetics.com/20260331/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetail Fair Value Measurements - Additional Information (Detail) Details 35 false false R36.htm 995785 - Disclosure - Balance Sheet Components - Reconciliation of Cash, Cash Equivalents, and Restricted Cash (Detail) Sheet http://cytokinetics.com/20260331/taxonomy/role/DisclosureBalanceSheetComponentsReconciliationOfCashCashEquivalentsAndRestrictedCashDetail Balance Sheet Components - Reconciliation of Cash, Cash Equivalents, and Restricted Cash (Detail) Details 36 false false R37.htm 995795 - Disclosure - Balance Sheet Components - Additional Information (Detail) Sheet http://cytokinetics.com/20260331/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetail Balance Sheet Components - Additional Information (Detail) Details 37 false false R38.htm 995805 - Disclosure - Balance Sheet Components - Accounts Receivable, Net (Detail) Sheet http://cytokinetics.com/20260331/taxonomy/role/DisclosureBalanceSheetComponentsAccountsReceivableNetDetail Balance Sheet Components - Accounts Receivable, Net (Detail) Details 38 false false R39.htm 995815 - Disclosure - Balance Sheet Components - Schedule of Inventories (Detail) Sheet http://cytokinetics.com/20260331/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfInventoriesDetail Balance Sheet Components - Schedule of Inventories (Detail) Details 39 false false R40.htm 995825 - Disclosure - Balance Sheet Components - Summary of Accrued Liabilities (Detail) Sheet http://cytokinetics.com/20260331/taxonomy/role/Role_DisclosureBalanceSheetComponentsSummaryOfAccruedLiabilitiesDetail Balance Sheet Components - Summary of Accrued Liabilities (Detail) Details 40 false false R41.htm 995835 - Disclosure - Debt - Additional Information (Detail) Sheet http://cytokinetics.com/20260331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail Debt - Additional Information (Detail) Details 41 false false R42.htm 995845 - Disclosure - Debt - Schedule of Interest Cost Relating to 2031 Notes, 2027 Notes and 2026 Notes (Detail) Notes http://cytokinetics.com/20260331/taxonomy/role/DisclosureDebtScheduleOfInterestCostRelatingTo2031Notes2027NotesAnd2026NotesDetail Debt - Schedule of Interest Cost Relating to 2031 Notes, 2027 Notes and 2026 Notes (Detail) Details 42 false false R43.htm 995885 - Disclosure - Stockholders' Equity - Additional Information (Detail) Sheet http://cytokinetics.com/20260331/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetail Stockholders' Equity - Additional Information (Detail) Details 43 false false R44.htm 995895 - Disclosure - Stockholders' Equity - Summary of Stock Options and Restricted Stock Units Granted (Detail) Sheet http://cytokinetics.com/20260331/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionsAndRestrictedStockUnitsGrantedDetail Stockholders' Equity - Summary of Stock Options and Restricted Stock Units Granted (Detail) Details 44 false false R45.htm 995915 - Disclosure - Stockholder's Equity - Summary of Stock-Based Compensation Expense (Detail) Sheet http://cytokinetics.com/20260331/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockbasedCompensationExpenseDetail Stockholder's Equity - Summary of Stock-Based Compensation Expense (Detail) Details 45 false false R46.htm 995925 - Disclosure - Commitments and Contingencies - Additional Information (Detail) Sheet http://cytokinetics.com/20260331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail Commitments and Contingencies - Additional Information (Detail) Details 46 false false All Reports Book All Reports cytk-20260331.htm cytk-20260331.xsd http://fasb.org/us-gaap/2025 http://xbrl.sec.gov/dei/2025 http://xbrl.sec.gov/ecd/2025 false false